nifuroxazide | Enterofuril capsules 100 mg, 30 pcs.

Release form

Capsules.

Packing

30 pcs.

Pharmacological action

Enterofuril® is a broad-spectrum antimicrobial agent that does not have a systemic effect and is used to treat diarrhea of ​​an infectious etiology.

Enterofuril® contains the active substance nifuroxazide, a drug of the 5-nitrofuran group of derivatives. The drug has a bactericidal and bacteriostatic effect against most pathogens of acute intestinal infections. The antimicrobial effect of nifuroxazide is dose-dependent: for example, low and medium doses of the drug have a bacteriostatic effect against pathogenic microflora, and high ones have a bactericidal effect.

The bacteriostatic mechanism of action of the drug is associated with inhibition of the activity of the enzyme dehydrogenase, which leads to disruption of the normal course of synthesis of vital compounds in the cell of the microorganism. So, due to the influence of nifuroxazide on the cell of the microorganism, there is a violation of the respiratory chain, inhibition of the tricarboxylic acid cycle.

In addition, Enterofuril® inhibits the synthesis of proteins in the cell of the microorganism and inhibits other biochemical processes in the bacterial cell. Thus, the cell of the microorganism loses its ability to reproduce.

Indications

Diarrhea of ​​bacterial origin.

CC) Contraindications

Fructose intolerance, glucose-galactose malabsorption syndrome, or sucrose insufficiency and other components of the drug have isomalt sensitivity age up to 3 years

Special instructions

When treating diarrhea concomitantly with nifuroxazide therapy, rehydration therapy (oral or intravenous) must be performed in accordance with the patient's condition and the intensity of diarrhea.

The use of alcohol during nifuroxazide therapy is prohibited.

Before prescribing a suspension in infants, it is necessary to exclude their congenital deficiency of enzymes that break down sucrose.

Influence on the ability to drive vehicles and work with mechanisms. The drug does not affect psychomotor activity and the ability to drive vehicles and work with mechanisms.

Composition

1 capsule contains:

active ingredient:

nifuroxazide 200 mg,

excipients:

sucrose - 71 mg

corn starch - 68 mg

MCC - 9 mg srdldkp magnesium 2

dioxide dye iron oxide yellow.

Dosage and Administration

Inside. Nifuroxazide therapy should not last more than 7 days.

For adults and children over 7 years of age, the drug is prescribed 1 capsule (200 mg) 4 times a day, the daily dose is 800 mg.

For children 3–7 years of age, the drug is prescribed 1 capsule (200 mg) 3 times a day, the daily dose is 600 mg.

Side effects

Allergic reactions (rash, urticaria, Quincke's edema, anaphylactic shock), nausea, vomiting.

Drug Interactions

Not described.

Overdose

The drug is not absorbed from the gastrointestinal tract and does not enter the systemic circulation.

Overdose symptoms are not known.

Gastric lavage and symptomatic treatment are recommended if the dose is exceeded.

Storage Conditions

At 15 to 30 РC.

Shelf life

3 years.

Active substance

Nifuroksazid

Terms and conditions otpuska IZ drugstore

Without prescription

dosage form

capsules

Possible product names

ENTEROFURIL 0, 1 N30 CAPSA

Enterofuril 100mg Caps. X30

Enterofuril 100mg No. 30

Enterofuril 100mg No. 30 caps

ENTEROFURIL 100MG. No. 30 CAPS.

Bosnalek, Bosnia and Herzegovina